Sanjaya Gupta, MD, MBA, details how his practice is leverage wearables as a patient engagement tool.

The Affordable Care Act is back in court this week after a Texas judge ruled the law unconstitutional in late 2018, prompting the American Heart Association and other major societies to issue a joint statement supporting the ACA and its protections for patients with pre-existing conditions.

Employees who work in what they consider a closed-off and untrusting environment are more likely to develop CVD risk factors like elevated blood pressure, high cholesterol and diabetes than those who feel their bosses support them, according to a study published in the International Journal of Environmental Research and Public Health.

The interventional cardiology devices market is expected to grow to $20.85 billion by 2022, a new report projects.

The Irish Hospital Consultants Association (IHCA) has launched a social media campaign, #CareCantWait, in response to a pervasive lack of access to medical care in the country.

The Affordable Care Act increased access to healthcare and health insurance for millions of Americans after it was first implemented five years ago. But for CVD patients in particular, some experts argue the law is falling short.

Medical directors of cardiac catheterization and EP labs receive three to four times the amount of money from pharmaceutical companies and device manufacturers as other interventional cardiologists in the same zip code, according to a JAMA Internal Medicine study.

French drugmaker Sanofi is cutting 466 jobs as part of an R&D “reshuffle” that will also put an end to the company’s new research efforts in cardiology.